

产品介绍 评论(0)
物种
Human抗原名称
CTLA4分子别名
CTLA4,CD152Accession
P16410表达序列
Ala37 - Phe162, with C-terminal Human IgG1 Fc &Avi tag表达宿主
HEK293分子量
43-55Reducing)
纯度
>95% by SDS-PAGE内毒素含量
<0.1EU/μg标记
Biotin标签
Human Fc Tag, Avi Tag性状
Lyophilized Powder缓冲体系
PBS, pH7.4溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.文献引用
1.Shuang Qin, Linping Xu, Ming Yi, Shengnan Yu,Kongming Wu & Suxia Luo: Novel immune checkpoint targets: moving beyondPD-1 and CTLA-4: MolecularCancer volume 18, Article number: 155 (2019).
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is an inhibitory receptor belonging to the CD28 immunoglobulin subfamily, expressed primarily by T-cells. The family includes CD28, CTLA-4 and ICOS as well as other proteins including PD-1, BTLA and TIGIT.Its ligands, CD80 and CD86, are typically found on the surface of antigen-presenting cells and can either bind CD28 or CTLA-4, resulting in a costimulatory or a co-inhibitory response, respectively. Because of its dampening effect, CTLA-4 is a crucial regulator of T-cell homeostasis and self-tolerance. The mechanisms by which CTLA-4 exerts its inhibitory function can be categorized as either cell-intrinsic (affects the CTLA-4 expressing T-cell) or cell-extrinsic (affects secondary cells). CTLA-4 mainly acts in a cell-extrinsic manner via its competition with CD28, CTLA-4-mediated trans-endocytosis of CD80 and CD86, and its direct tolerogenic effects on the interacting cell.
电泳
- 1μg (R: reducing conditions, N: non-reducing conditions).
ELISA
Immobilized Anti-Human CTLA4 Monoclonal Antibody (Ipilimumab) at 2.0μg/mL (100μL/well) can bind Biotinylated CTLA4 Fc&Avi Tag, Human (Cat. No. UA010484)with EC50 of 3.86-4.98ng/mL.







评论(0)